An overview of Creutzfeldt-Jakob disease associated with the use of human pituitary growth hormone.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Developments in biological standardization

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1794632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Recombinant Human Thyroid-Stimulating Hormone

  2012cites this paper
• The effects of recombinant human thyrotropin, in normal subjects and patients with goitre

  2004cites this paper
• European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors.

  2000cites this paper
• Usefulness of recombinant human prolactin for treatment of poor puerperal lactation in a rat model.

  1995cites this paper
• Creutzfeldt-Jakob disease:another avenue?

  1994cites this paper
• Ensuring safety and consistency in cell culture production processes: viral screening and inactivation.

  1994cites this paper
• [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].

  1993cites this paper
• Neuropathology of spongiform encephalopathies in humans.

  1993cites this paper
• Recombinant Human Thyroid Stimulating Hormone: Development of a Biotechnology Product for Detection of Metastatic Lesions of Thyroid Carcinoma

  1993cites this paper